Torén Kjell, Olin Anna-Carin, Lindberg Anne, Vikgren Jenny, Schiöler Linus, Brandberg John, Johnsson Åse, Engström Gunnar, Persson H Lennart, Sköld Magnus, Hedner Jan, Lindberg Eva, Malinovschi Andrei, Piitulainen Eeva, Wollmer Per, Rosengren Annika, Janson Christer, Blomberg Anders, Bergström Göran
Section of Occupational and Environmental Medicine, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Public Health and Clinical Medicine, Division of Medicine/Respiratory Medicine, Umeå University, Umeå, Sweden.
Int J Chron Obstruct Pulmon Dis. 2016 May 2;11:927-33. doi: 10.2147/COPD.S104644. eCollection 2016.
Spirometric diagnosis of chronic obstructive pulmonary disease (COPD) is based on the ratio of forced expiratory volume in 1 second (FEV1)/vital capacity (VC), either as a fixed value <0.7 or below the lower limit of normal (LLN). Forced vital capacity (FVC) is a proxy for VC. The first aim was to compare the use of FVC and VC, assessed as the highest value of FVC or slow vital capacity (SVC), when assessing the FEV1/VC ratio in a general population setting. The second aim was to evaluate the characteristics of subjects with COPD who obtained a higher SVC than FVC.
Subjects (n=1,050) aged 50-64 years were investigated with FEV1, FVC, and SVC after bronchodilation. Global Initiative for Chronic Obstructive Lung Disease (GOLD) COPDFVC was defined as FEV1/FVC <0.7, GOLDCOPDVC as FEV1/VC <0.7 using the maximum value of FVC or SVC, LLNCOPDFVC as FEV1/FVC below the LLN, and LLNCOPDVC as FEV1/VC below the LLN using the maximum value of FVC or SVC.
Prevalence of GOLDCOPDFVC was 10.0% (95% confidence interval [CI] 8.2-12.0) and the prevalence of LLNCOPDFVC was 9.5% (95% CI 7.8-11.4). When estimates were based on VC, the prevalence became higher; 16.4% (95% CI 14.3-18.9) and 15.6% (95% CI 13.5-17.9) for GOLDCOPDVC and LLNCOPDVC, respectively. The group of additional subjects classified as having COPD based on VC, had lower FEV1, more wheeze and higher residual volume compared to subjects without any COPD.
The prevalence of COPD was significantly higher when the ratio FEV1/VC was calculated using the highest value of SVC or FVC compared with using FVC only. Subjects classified as having COPD when using the VC concept were more obstructive and with indications of air trapping. Hence, the use of only FVC when assessing airflow limitation may result in a considerable under diagnosis of subjects with mild COPD.
慢性阻塞性肺疾病(COPD)的肺量计诊断基于1秒用力呼气容积(FEV1)/肺活量(VC)的比值,该比值可以是固定值<0.7,或者低于正常下限(LLN)。用力肺活量(FVC)可作为VC的替代指标。第一个目的是比较在一般人群中评估FEV1/VC比值时,使用FVC和VC(以FVC或慢肺活量(SVC)的最高值来评估)的情况。第二个目的是评估COPD患者中SVC高于FVC的患者的特征。
对年龄在50 - 64岁的1050名受试者进行支气管扩张后的FEV1、FVC和SVC检查。慢性阻塞性肺疾病全球倡议(GOLD)COPDFVC定义为FEV1/FVC <0.7,GOLDCOPDVC定义为使用FVC或SVC的最大值时FEV1/VC <0.7,LLNCOPDFVC定义为FEV1/FVC低于LLN,LLNCOPDVC定义为使用FVC或SVC的最大值时FEV1/VC低于LLN。
GOLDCOPDFVC的患病率为10.0%(95%置信区间[CI] 8.2 - 12.0),LLNCOPDFVC的患病率为9.5%(95% CI 7.8 - 11.4)。当基于VC进行评估时,患病率更高;GOLDCOPDVC和LLNCOPDVC分别为16.4%(95% CI 14.3 - 18.9)和15.6%(95% CI 13.5 - 17.9)。与无任何COPD的受试者相比,基于VC被归类为患有COPD的额外受试者组的FEV1更低、喘息更多且残气量更高。
与仅使用FVC相比,使用SVC或FVC的最高值计算FEV1/VC比值时,COPD的患病率显著更高。使用VC概念时被归类为患有COPD的受试者阻塞性更强且有气体潴留的迹象。因此,在评估气流受限情况时仅使用FVC可能会导致轻度COPD患者的诊断明显不足。